Injective vs Maple Finance — how do they compare? Injective trades at Rp75,915 (market cap Rp7,49T, Rp831,89M 24h volume), while Maple Finance trades at Rp2,682 (market cap Rp3,18T, Rp76,88M 24h volume). The key difference: Injective is far larger — about 2.4× Maple Finance's market cap, and Injective's circulating supply is 100M INJ versus 1,2B SYRUP for Maple Finance. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Maple Finance for 14 Days on average.
| INJ | SYRUP | |
|---|---|---|
Market Cap | Rp7,49T | Rp3,18T |
Volume (24h) | Rp831,89M | Rp76,88M |
Circulating Supply | 100M INJ | 1,2B SYRUP |
Typical Hold Time | 37 Days | 14 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
SYRUP is trading at Rp2,763 with a market cap of Rp3.29T, showing a bearish technical signal as moving averages indicate selling pressure while oscillators are neutral. Key support lies at Rp2,549 and resistance at Rp2,801. No major protocol updates or ecosystem news were found recently.
The outlook is cautious due to bearish technicals and lack of fundamental catalysts. Opportunities include potential bounces from support levels, but risks involve low liquidity and high volatility. Investors should monitor for any new ecosystem developments.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Maple, launched in 2021, is an on-chain asset manager that combines decades of experience in traditional finance and cryptocurrency. By merging capital markets expertise with DeFi innovation, Maple offers a variety of products, including secured lending, Bitcoin yield strategies, and structured financial instruments.
Read more on SYRUP →